Another USFDA Alert For Ranbaxy
  • Elizabeth George
  • Sep 24 2013

September 24: Ranbaxy is in the spotlight again with global regulators starting to show concern. Reports suggest that the European and Australian regulators have sought information from the US FDA on company practices. Meanwhile, USFDA is looking into practices being followed at the Ohm facility in US, which is the only facility of Ranbaxy catering to the entire market now. We also trace the stock since the Daiichi Sankyo acquisition to where it stands right now.